# Hetero Labs Limited - Unit III, Hyderabad, India – FDA Inspections

Source: https://www.keypedia.com/companies/hetero-labs-limited-unit-iii/8b051c13-41f2-4f52-a2cd-d5736ca72735

> Inspection records and compliance data for Hetero Labs Limited - Unit III in Hyderabad. 9 FDA inspections on record, 5 Form 483s, last inspected July 21, 2023.

---

## Details

- Name: Hetero Labs Limited - Unit III
- FEI Number: 3005406526
- Business Operations: FDF MANUFACTURE
- Address Line 1: Plot 22-110, Part-Ii, Ida, Jeedimetla
- City: Hyderabad
- Country Name: India
- Address: Plot 22-110, Part-Ii, Ida, Jeedimetla, Hyderabad, India
- Country: India

## Related Documents

- [483 - Hetero Labs Limited - Unit III - 2025-09-26](https://www.keypedia.com/records/483/hetero-labs-limited-unit-iii/86f55314-aeba-4447-9011-2005c17c759d) — source: FDA, date: September 26, 2025
- [483 - Hetero Labs Limited - Unit III - 2023-07-21](https://www.keypedia.com/records/483/hetero-labs-limited-unit-iii/8eb74200-1af3-4dc8-9a05-2f583d07f9f3) — source: FDA, date: July 21, 2023
- [FDA Inspection 1210507 - Hetero Labs Limited - Unit III - 2023-07-21](https://www.keypedia.com/records/fda_inspections/hetero-labs-limited-unit-iii/37fbf479-c308-420c-8007-fed01c365dbe) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 21, 2023
- [483 - Hetero Labs Limited - Unit III - 2019-06-07](https://www.keypedia.com/records/483/hetero-labs-limited-unit-iii/36e5da2c-e813-4ebd-a09d-d5e8f71f6cd7) — source: FDA, date: June 7, 2019
- [FDA Inspection 1092347 - Hetero Labs Limited - Unit III - 2019-06-07](https://www.keypedia.com/records/fda_inspections/hetero-labs-limited-unit-iii/0d583d9c-18e6-405d-afa9-92fe6aab6286) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 7, 2019
- [483 - Hetero Labs Limited - Unit III - 2018-10-26](https://www.keypedia.com/records/483/hetero-labs-limited-unit-iii/3adb6ed3-d4b8-482d-aecf-624f8ceb7aa5) — source: FDA, date: October 26, 2018
- FDA Inspection 1071009 - Hetero Labs Limited - Unit III - 2018-10-26 — source: FDA, date: October 26, 2018
- [FDA Inspection 1071009 - Hetero Labs Limited - Unit III - 2018-10-26](https://www.keypedia.com/records/fda_inspections/hetero-labs-limited-unit-iii/67944bc2-338c-4533-a2e7-85603555e425) — source: FDA, date: October 26, 2018
- [483 - Hetero Labs Limited - Unit III - 2018-03-23](https://www.keypedia.com/records/483/hetero-labs-limited-unit-iii/d1ca9b7b-3013-41e7-88ec-e22d4393afa4) — source: FDA, date: March 23, 2018
- FDA Inspection 1045339 - Hetero Labs Limited - Unit III - 2018-03-23 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 23, 2018
- [FDA Inspection 1045339 - Hetero Labs Limited - Unit III - 2018-03-23](https://www.keypedia.com/records/fda_inspections/hetero-labs-limited-unit-iii/cdeffc5b-480c-4fe1-a8c6-e0e93c6be909) — classification: No Action Indicated (NAI), source: FDA, date: March 23, 2018
- 483 - Hetero Labs Limited - Unit III - 2016-10-26 — source: FDA, date: October 26, 2016
- [FDA Inspection 993030 - Hetero Labs Limited - Unit III - 2016-10-26](https://www.keypedia.com/records/fda_inspections/hetero-labs-limited-unit-iii/6950965a-2a58-407d-92cd-3aab7a4e5d09) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 26, 2016
- FDA Inspection 993030 - Hetero Labs Limited - Unit III - 2016-10-26 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 26, 2016
- [483 - Hetero Labs Limited - Unit III - 2015-07-31](https://www.keypedia.com/records/483/hetero-labs-limited-unit-iii/098a47d1-43ad-4275-b9d6-eb6b501b19fa) — source: FDA, date: July 31, 2015
- [FDA Inspection 940470 - Hetero Labs Limited - Unit III - 2015-07-31](https://www.keypedia.com/records/fda_inspections/hetero-labs-limited-unit-iii/26e19681-5a32-4b18-ac17-f1bd8a6b23f1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 31, 2015
- FDA Inspection 852628 - Hetero Labs Limited - Unit III - 2013-10-11 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 11, 2013

## Related Companies

- [Haw Par Healthcare Limited](https://www.keypedia.com/companies/haw-par-healthcare-limited/4624588e-3f62-4c4c-8ea2-297ba6465337)
- [Jamol Laboratories, Inc.](https://www.keypedia.com/companies/jamol-laboratories-inc/acd4c51c-2154-464d-bbc0-01477a7e4917)
- [Sinsin Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/sinsin-pharmaceutical-co-ltd/3d12e29a-e9ed-4ddf-b655-01426b120c0b)
- [Woodbine Products Company](https://www.keypedia.com/companies/woodbine-products-company/b7fae119-8c1a-44b5-b3ce-11c0750b7689)
- [Apothecus Pharmaceutical Corp.](https://www.keypedia.com/companies/apothecus-pharmaceutical-corp/d37c243b-2226-4d18-9931-7a3b915e3199)
- [InvaGen Pharmaceuticals, Inc.](https://www.keypedia.com/companies/invagen-pharmaceuticals-inc/8841516b-25bb-463f-9666-11b69458c306)
- [Parfums Christian Dior](https://www.keypedia.com/companies/parfums-christian-dior/59c23185-69df-4e7d-a609-bd4b8ed2af94)
- [EO Products, LLC](https://www.keypedia.com/companies/eo-products-llc/5ca6500c-60f8-43a0-a6b6-cde349d9dd77)
- [World Perfumes Inc.](https://www.keypedia.com/companies/world-perfumes-inc/97d75c90-5a60-4810-8ffb-5c48b7fcea9c)
- [Wild Child Laboratories Pty Ltd.](https://www.keypedia.com/companies/wild-child-laboratories-pty-ltd/b52942c7-79c3-41bd-ab62-a8b3ddd6fb6b)

## Related Officers

- [Investigator](https://www.keypedia.com/people/lucas-b-leake/f4c191d4-25d1-4eb8-8dc9-4d1aa483a441)
- [Pratik S. Upadhyay](https://www.keypedia.com/people/pratik-s-upadhyay/22ff2e0b-17d4-4c91-a3f0-c7e30b7a115b)
- [Rita Kabaso](https://www.keypedia.com/people/rita-kabaso/a8383d6d-b945-4edc-97a4-90944574835d)
